Related references
Note: Only part of the references are listed.Survival and Prognostic Analysis after Pulmonary Metastasectomy for Head and Neck Cancer
Wojciech Dudek et al.
THORACIC AND CARDIOVASCULAR SURGEON (2021)
Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer
Dario Pasalic et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Oligometastatic head and neck cancer: Comprehensive review
Toms Vengaloor Thomas et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma
Ciro Franzese et al.
JOURNAL OF UROLOGY (2019)
Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes
James E. Bates et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Danny Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Pierluigi Bonomo et al.
ORAL ONCOLOGY (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Survival and prognostic factors after pulmonary metastasectomy of head and neck cancer: what are the clinically informative prognostic indicators?
Tomonari Oki et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2019)
Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape
Remco de Bree et al.
ADVANCES IN THERAPY (2018)
Improved overall survival in head and neck cancer patients after specific therapy of distant metastases
Dominik Schulz et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2018)
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC
Xu Shan Sun et al.
FUTURE ONCOLOGY (2018)
The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
Ciro Franzese et al.
CANCER MEDICINE (2018)
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
Marta Scorsetti et al.
RADIATION ONCOLOGY (2018)
Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy
Chad G. Rusthoven et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma
Ali Hosni et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques
Jonathan E. Leeman et al.
JAMA ONCOLOGY (2017)
Overview of the 8th Edition TNM Classification for Head and Neck Cancer
Shao Hui Huang et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer
Mitsutoshi Ooishi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis
E. R. Young et al.
CLINICAL OTOLARYNGOLOGY (2015)
Radiation Oncology-New Approaches in Squamous Cell Cancer of the Head and Neck
Danielle N. Margalit et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Assuntina G. Sacco et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Local ablative treatments of oligometastases from head and neck carcinomas
C. Florescu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
Kimberly S. Corbin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects
Robert P. Takes et al.
ORAL ONCOLOGY (2012)
Determinants and Patterns of Survival in Adenoid Cystic Carcinoma of the Head and Neck, Including an Analysis of Adjuvant Radiation Therapy
Shane Lloyd et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions
Michael T. Milano et al.
CANCER (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Liver Metastases from head and neck squamous cell carcinomas: Radiological and biological features
PY Marcy et al.
ONKOLOGIE (2004)
Incidence and sites of distant metastases from head and neck cancer
A Ferlito et al.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES (2001)